Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway

• Main Authors: Fenglin Luo (Author), Yimeng Tang (Author), Lin Zheng (Author), Ying Yang (Author), Haoyue Gao (Author), Shiya Tian (Author), Hongyu Chen (Author), Chenxi Tang (Author), Shanshan Tang (Author), Qiong Man (Author), Yiying Wu (Author)
• Format: Book
• Published: MDPI AG, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Colorectal cancer (CRC) is one of the most common malignancies. Isoliquiritigenin (ISL), a flavonoid phytoestrogen, has shown anti-tumour activities against various cancers. However, its anti-CRC mechanism has not been clarified. In this study, the potential molecular mechanism of ISL against CRC wa...